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Alterations of glomerular podocytic processes in immunologically me-
diated glomerular disorders. The importance of the relationship between
the alteration of podocytic processes (PP) and proteinuria has been
controversial for almost 30 years. In spite of several morphometric
studies the range of PP alterations in different proteinuric conditions has
gone unnoticed. Thus, we studied the distribution of abnormally
broadened PP in different glomerulopathies and in normal controls
(children and adults). We found a highly variable mean PP-width in all
proteinuric patients, values that were, however, always clearly distinct
from normal controls in children and adults. A correlation between the
extent of PP alteration and the amount of proteinuria was not found (r
= 0.09) for the group as a whole or for the different clinico-pathological
entities. In proteinuric patients 15 to 50% of all PP were broadened and
covered 40 to 60% of the total length of the peripheral capillary loop.
We conclude that the alteration of PP in various proteinuric conditions
is variable and does not correlate with the level of proteinuria. These
studies further suggest that other mechanisms, possible hemodynamic
adaptation in response to the capillary wall injury, might play a role in
the permeability changes observed in these patients.
For the past 25 years, it has been known that the loss of
interdigitating podocytic processes (PP) of the glomerular epi-
thelium is a prominent feature of minimal change disease
(MCD) [1, 2] and other glomerulopathies (GP) that present with
the nephrotic syndrome [3—6]. Though not selective for MCD,
the PP-alteration was thought to be a highly characteristic,
diagnostic feature [1]. In this regard Churg, Grishman and
Goldstein [7] introduced the term "foot—process—disease" for
this special clinicopathologic entity. Commonly, the glomerular
epithelial cell alteration is referred to as "fusion" of PP.
However, scanning electron microscopic studies performed in
puromycine aminonucleoside nephrosis—an experimental mo-
del of MCD—have shown that this phenomenon is a result of a
PP-retraction and subsequent flattening of the podocytic cell
body rather than a fusion of adjacent pedicles [8]. The impor-
tance of this PP-alteration and its relationship to proteinuria has
been the subject of significant controversies ever since discrep-
ancies were noted in the onset [9, 10], and the degree of
proteinuria and the variability of morphologic changes [11]. In
the last few years, several investigators have tried to relate the
extent of PP-alteration to the degree of proteinuria [4, 12—14] or
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to the decline in glomerular filtration rate [15]. These studies
have often yielded controversial results. In most of these
studies it has been assumed that the PP-alteration is a general-
ized phenomenon and little attention has been paid to the
variability of this structural abnormality.
Thus, the aim of this study was to investigate the degree and
the variability of PP-alteration in various proteinuric conditions
and to determine the correlation of standard parameters that
define this abnormality with the degree of urinary protein
excretion.
In accordance with our preliminary observations [16, 17], we
conclude that, although an enlargement of PP is consistently
present in proteinurie states, a correlation between the extent of
this structural alteration and the severity of the permeability
defect is not readily apparent. Our observations suggest that
other factor(s) in addition to the structural changes are respon-
sible for the degree of protein loss in the urine.
Methods
Materials
Kidney biopsies of 58 patients were studied. The selected
tissue specimen contained at least five glomeruli from the
subcapsular region for structural evaluation. The morphologic
diagnosis of each kidney biopsy was based on morphological
and clinical parameters thought to be typical for a certain
disease entity. Table 1 lists the morphologic diagnosis, number
of cases studied per entity, and the range of age and proteinuria
for all cases. The protein excretion values are those measured
immediately prior to biopsy. Morphological criteria used for the
classification of the various disease entities have been described
in detail elsewhere [18, 19]. The control group of biopsies
included samples from patients who underwent staging lapara-
tomy for tumor metastasis (adults) and from patients with
asymptomatie microscopic hematuria (children) that underwent
renal biopsy and in whom an extrarenal source for the hematu-
na became evident subsequently to the renal biopsy. All control
kidneys had structurally intact renal cortical elements.
General preparation of tissue specimen
All kidney biopsies were studied by light, immunofluores-
cenee, and transmission electron microscopy. For light micros-
copy, the tissue was fixed in 4% buffered formaldehyde or in
Dubosq-Brasil, followed by routine dehydration and paraf-
fin—embedding. The sections were stained with hematoxilin and
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Table 1. Number, range of age and proteinuria of all diagnostic
groups studied
Group
Number
of cases
Age—range
years
Proteinuria
g/24 hr
Controls
Children
Adults
All
7
5
12
4—11
19—49
0
0
MCD
Children
Adults
All
10
9
19
3—15
17—51
5.0—35.0
7.0—13.0
MPGN
Type I
Type II
All
4
3
7
11—49
17—31
2.7— 8.0
1.8— 7.0
MGN
Mes PGN
All
7
9
4
13
16—50
9—49
2—24
1.2—11.6
0.7— 2.0
3.0—21.0
Abbreviations are: MCD, minimal change disease; MPGN, mem-
brano-proliferative glomerulonephritis; MGN, membranous glomerulo-
nephritis; Mes PGN, mesangial proliferative glomerulonephritis.
a Etiology of cases with Mes PGN: (a) proteinuria less than 2.5g/24
hr, included are 8 cases of IgA nephritis an 1 case of uncertain
classification; and (b) proteinuria more than 2.5g/24 hr; included are 2
cases of postinfectious glomerulonephritis and 2 cases of uncertain
classification (no immune complexes detectable by immunofluores-
cence and electron microscopy)
eosin, Pearse's trichrome, Periodic—acid Schiff, Goidner's tn-
chrome and Jones' Chromotrop 2R silver stain. Direct immu-
nofluorescence was performed as described earlier [201. For
electron microscopy, the tissue was fixed in buffered 3%
glutaraldehyde, dehydrated and embedded in epoxy resin. Thin
sections were stained with uranyl acetate and lead citrate and
examined with a Philips EM 301 microscope.
In order to study the alterations of the shape of podocytic
processes (PP) of the peripheral capillary loop, transversely cut
glomeruli with patent capillary lumina were selected preferen-
tially from the subcapsular region and photomicrographs of the
entire length of randomly selected capillary loops were taken
and enlarged to a final standard magnification of 11.000 x.
Morphometric analysis was performed using a MOP Digiplan
morphometric unit (Kontron GmbH, Munich, West Germany),
while the statistical calculations were done on a HP 41C
calculator (Hewlett Packard, Elkhart, Indiana, USA) equipped
with a statistical module.
Morphometric analysis
In the present study we analyzed the alteration of the shape
of PP that cover the peripheral glomerular capillary loop; those
PP overlying the mesangial region were excluded from the
calculations. The shape of PP is best characterized by the
so—called PP-width, which we have defined operationally as the
linear distance between the outer, left parietal edge of one PP to
the adjacent process located on the right (thus including the
length of one slit—diaphragm); this distance is measured at the
level of the PP basal cell membrane adjacent to the glomerular
basement membrane.
As basic statistical analysis we established the number of
capillary loops that need to be studied to obtain a representative
measurement of the PP width per glomerulus in proteinuric
states. Thus, using 10 and 20 capillary loops per glomerulus in
six cases of MCD with five glomeruli each, the average width of
PP per individual capillary loop was calculated as the ratio
between the length of peripheral capillary wall and its total
number of PP. Then, the mean PP width standard deviation
(SD) per glomerulus was determined using the average values of
PP width determined from each individual capillary loop. From
these data, the cumulative standard error (csE) was calculated
using measurements for 5, 10, 15, and 20 capillary loops per
glomerulus and expressed as the percentage of the mean
glomerular PP width [21]. The adequacy of the standard sam-
pling (10 loops per glomerulus) was also demonstrated in all
other cases by calculating the csE, according to Bolender [22].
The variability of the average PP-width from one glomerulus to
another in proteinuric patients was analyzed in five glomeruli
each in six cases of MCD. For this purpose, the average
PP-width obtained from 20 capillary loops per glomerulus by
the method outlined above in each of five glomeruli per case
was compared by one—way analysis of variance (ANOVA) and
followed, when pertinent, by multiple pairwise comparison and
computation of modified t-statistics [23]. In the 12 controls,
only one glomerulus per case was analyzed, since under normal
conditions PP-width has been reported to be a stable parameter
from one glomerulus to another [24].
This morphometric analysis provided the basis for additional
studies in which the data obtained for PP-width in several
immunologically mediated glomerular disorders were expressed
in three different ways.
Mean PP-width in different proteinuric conditions. The mean
PP-width per glomerulus was calculated as the average value of
the PP-width of 10 single capillary loops in which the individual
ratio between the length of a peripheral basement membrane
and its total number of PP was determined.
Frequencies of PP-width in various glomerular disorders. PP
were classified in 1 pm increments and the frequency of each
class of PP (in %) plotted graphically for each disease entity and
for the controls. Furthermore, the correlation coefficient was
calculated in each group for the relationship between the
frequency of PP-width greater than 2.0 pm or 7.0 pm and the
level of proteinuria.
Fractional surface of the glomerular capillary wall covered
by PP of various size classes. The results of these measure-
ments are presented in bar diagrams, showing the fraction of the
length of the capillary loop covered by PP of four size classes:
less than 2.0 pm, 2.1 to 4.5 m, 4.6 to 7.0 pm, and wider than
7.0 m. The correlation coefficient was calculated for the
relationship between the fraction of capillary loop covered by
PP wider than 2.0 m or 7.0 tm and the level of proteinuria in
the various disease groups and controls.
Results
The cumulative standard error (csE) as percentage of the
mean PP width in six cases of MCD with five glomeruli each
was on average 6.16 1.98% for 20 capillary loops per
glomerulus and increased slightly when the cs was based on
only 10 capillary loops per glomerulus (7.88 2.08%, mean
SD). Similar values were obtained for all other cases of MCD (in
S[1111Ft
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Table 2. ANOVA data of six cases of minimal change disease
Case number 1 2 3 7 8 9
Proteinuriag/24hr
Fvaluea
P
Multiple
comparison
7.0
1.95
NS
NA
7.3
0.52
NS
NA
7.5
2.8!
<0.05
NSb
11.0
1.85
NS
NA
12.0
0.78
NS
NA
35.0
2.13
NS
NA
children: 8,00 2.29%; in adults: 7.32 1.62%) using 10
capillary loops per glomerulus. An CSEof less than 10% was
also found in all normal control cases in children (5.46 1.90%)
and in adults (6.91 1.25%) and in mesangial proliferative
glomerulonephritis (Mes PGN) with a proteinuria of less than
2.5 g124 hrs. (7.13 3.0%). In other proteinuric conditions the
average CSE established for 10 capillary loops per glomerulus
was slightly higher (Mes PGN with proteinuria greater than 2.5
g/24 hr: 12.18 2.80%; MPGN: 13.02 3.13%; MGN: 15.11
2.96%).
The average PP width calculated in different glomeruli in each
of six cases with MCD shows little variability, as shown in
Figure 1. The results of the one way ANOVA performed on five
glomeruli of each case are summarized in Table 2. Except in
case 3, in the other five cases (cases 1, 2, 7, 8 and 9) the
difference of the mean PP width among the five glomeruli
studied per case was not statistically significant. When in case
3 a multiple pairwise comparison was performed and analyzed
by the Bonferroni method, the difference between the mean PP
width calculated for each of the five glomeruli was no longer
statistically significant.
Since the CSE as a percentage of the mean PP width did not
differ significantly when either 20 or 10 capillary loops per
glomerulus were studied, and the variability of the mean PP
width per glomerulus from one glomerulus to another within a
given case is small, we used for practical purposes 1 glomerulus
with 10 capillary loops per case for all further measurements of
PP width.
Table 3. Results of mean PP-width and range of
peripheral glomerular capillary loop in all
PP per 10 m of
groups
Mean PP-
Group width
Range of
PP/10m
Controls
Children 0.56 0.06
Adults 0.64 0.06
All 0.59 0.70
14.2—22.2
14.4—18.0
MCD
Children 1.78 0.59
Adults 1.42 0.26
All 1.60 0.8la
4.2— 8.4
5.7—11.4
MPGN 1.44 0.46a 5.3—12.8
MGN 2.07 0.37a 4.9— 8.1
Mes PGN
<2.5 g/24 hr 1.18 0.14
>2.5 g/24 hr 2.39 0.70
All 1.55 0.69a
7.4—10.3
3.1— 6.7
Mean PP-width in d/ferent proteinuric conditions
The results of our calculation of the mean PP-width for each
disease group are summarized in Table 3. Here, we have also
included the range of PP per 10 m of peripheral glomerular
basement membrane. These data show that the mean PP-width
is clearly distinct in proteinuric diseases when compared to
controls, with no overlap between diseased and normals. How-
ever, we found no correlation between the increase of mean
PP-width and the degree of proteinuria when this relationship
was analyzed for all cases (correlation coefficient r = 0.09) (Fig.
2). Within any group, a positive correlation does not existent or
is very weak with r values ranging from —0.25 to 0.38. Further-
more, there is a considerable variation of the mean PP-width for
similar levels of proteinuria not only between the different
groups of diseases but also, and more importantly, within the
same group. In our control group the difference in PP-width
between adults and children was not statistically significant
(Table 3).
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Fig. 1.Minimal change disease, mean width of podocytic processes and
standard deviation is shown per 5 glomeruli per case; 20 capillary loops
were measured in each glomerulus. Proteinuria (g/24hr): case 1—5,0 g,
case 2—11.0 g, case 3—7.0 g, case 7—12.0 g, case 8—7.3 g, case 9—
35.0 g.
a Critical value F005 (4, 95 = 2.46)
b Calculated modified I for 10 comparisons ranged from 0.003 to
0.1325; critical t value = 2.878 by df = 95, m = 10 comparisons
,,o o,p °
I Controls
a P < 0.05 when compared to control groups by one—way ANOVA
2.0 •
:
1.0
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0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 20 35
Proteinuria g/24 hrs
FIg. 2. Relationship between mean PP-width and protein excretion rate
in different glomerulopathies and controls (U). Symbols are: (Li) adults
having MCD, (A) children having MCD, (0) mesangial proliferative
GN, (•) MGN, (0) MPGN. Y= 1.57 + 0.OIX; r = 0.09.
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Fig. 3. Frequency distribution of PP classlpea in intet vals of 1 p.m increments for the d(fferent glomerulopathies (O----O) and controls (D — Li).
A. Mes PGN > 2,5 g/24 hr; B. MPGN; C. Mes PGN < 2.5 g/24 hr; D. MGN.
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Width of podocytic processes,
Fig. 4. PP-alterations in children (left) and adults (right) in minimal change disease and in normal controls. A. Frequency distribution with
PP-width intervals of 1 m increments. Symbols are: (•) control group and (•) MCD. B. Bar area diagrams showing the fraction of capillary loop
length covered by PP divided into 4 classes of different width. Symbols are: (LI) 0 to 2,0, (111) 2:1 to 4.5, (Li) 4.6 to 7.0, and (•) > 7.0 p.m.
Frequences of PP-width in various glomerulopathies
Since the mean PP-width did not allow any statement about
the degree of alteration of PP-width between cases, within
groups, we measured the length of individual PP and grouped
the width in classes of 1 p.m increments. The results are
presented in frequency plots for each group in Figures 3 and 4.
For controls, the percentage of classes of different PP-width did
not differ between adults and children: about 98% of all PP were
less than 2.0 p.m in width (of which about 60% were between 0.2
and 0.4 p.m) while there were no PP wider than 3 p.m in adults
or 4 p.m in children. In all diseased glomeruli, however, the
frequency of PP less than 2.0 p.m in width was markedly
reduced. We found between 15 and 50% of PP larger than 2.0
p.m regardless of the degree of proteinuria. In all cases the
highest percentage of enlarged PP was represented by PP
between 2.1 and 4.5 p.m (10 to 30%), while PP greater than 7.0
p.m in width represented only between 0.3 and 10%. No
relationship was found between the frequency of PP wider than
2.0 p.m or 7.0 p.m and proteinuria (correlation coefficient r
0.24 and r = 0.141, respectively).
Fractional surface of the glomerular capillary wall covered
by PP of various size classes
To determine the extent of the peripheral capillary wall
covered by PP of different width, we transferred the above
mentioned results into bar area diagrams (Figs. 4 and 5). While
PP less than 2.0 p.m covered about 94% of capillary basement
membrane in controls, in disease states normal sized PP (less
than 2.0 p.m) covered between 40 and 60% of the peripheral
GBM. On the other hand, PP wider than 7.0 p.m in width
covered only 2 to 19% of the total capillary basement membrane
in proteinuric conditions. Again, we found a remarkable degree
of variation within each group even at comparable degrees of
proteinuria, as is shown for MCD in Figure 4. No relationship
could be detected between the fraction of capillary wall covered
by PP wider than 2.0 p.m or 7.0 p.m and proteinuria (correlation
coefficient r = 0.146 and r = 0.10, respectively).
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Controls (children and
adults)
<2.5 g prot./24 hrs
Mes. prolif. GN
>2.5 g prot./24 hrs
MCD
(children and adults)
MGN
MPGN
0 50 100%
Width of podocytic processes, jim
Fig. 5. Bar area diagrams of all groups showing the percentage of
PP-width in four classes covering the capillary surface. Symbols are the
same as Figure 4B.
Discussion
Our analysis of PP in different proteinuric conditions and
normal control kidneys increases our knowledge in the func-
tional and structural importance of PP broadening and its
relationship to proteinuria not only between but also within
groups of different immunologically mediated glomerular disor-
ders and normal controls. In normal kidneys the mean PP-width
seems to be remarkably constant regardless of the age of the
individual. This finding has only been described for adults [24].
Having established this result for both, adults and children, PP
with dimensions of above 2.0 p.m should be considered broad-
ened. Even if we assume that a certain amount of PP are cut at
various angles with respect to their long axis, the number of PP
above 2.0 p.m in width is negligible in normal control kidneys.
The mean PP-width in all proteinuric patients is distinct from
the normal control kidneys with no overlap between these
values (Fig. 2). Thus, an increase of mean PP-width is always
accompanied by proteinuria regardless of the underlying type of
glomerulopathy, and such changes can be detected by morpho-
metric means.
Our findings confirm previous studies performed on various
proteinuric disorders [12, 14, 25]. However, Seefeldt et al [14]
report proteinuric patients with PP of normal width. We have
not been able to substantiate their finding in our patient popu-
lation.
Although enlargement of PP-width seems to be a general
morphologic feature in proteinuria, there is little correlation
between the extent of PP-alteration and the amount of protein-
uria (correlation coefficient r = 0.09) (Fig. 2). In addition, we
find a large variability of the mean PP-values not only between
groups of different glomerulopathies but also, and more impor-
tantly, within the same disease with similar levels of protein-
uria. This finding indicates that besides the missing correlation
between the extent of PP-alteration and the amount of protein-
uria in general, there is at best only a weak correlation between
these parameter within each disease, as is indicated by the low
correlation coefficient for each group. This finding is in direct
conflict with two previous reports of MCD in children [13, 15],
where a correlation and linear relationship between enlarge-
ment of PP and amount of proteinuria is described. In the study
of Powell [13] this correlation (r = 0.93) was demonstrated for
a selected subgroup of 17 out of 24 cases in children with MCD.
The reason for this difference is not readily apparent. In the
second report, Bohman et al [15] analyzed the relationship
between the glomerular filtration rate, the effective renal blood
flow and the PP-width in 14 of MCD cases with either heavy
proteinuria (8 cases) or in incomplete or complete remission of
the disease (6 cases). Although their results show that the
glomerular filtration rate is inversely related to the degree of
foot process fusion (r =
—0.859) for all 14 cases, this relation-
ship seems to be fulfilled only in three out of the eight cases with
heavy proteinuria. A similar relationship was demonstrated
between the serum albumin concentration and the degree of
foot process fusion (r =
—0.756), yet from the data provided
only a weak correlation can be calculated for cases with heavy
proteinuria (r = —0.51). Finally, in our own study an apprecia-
ble number of PP are enlarged in proteinuric patients as
compared to the control population. Thus, the frequency of PP
less than 2.0 p.m in width is reduced from 98% (in control
kidneys) to values between 50 and 85% in proteinuric states.
However, each single class of PP wider than 3.0 p.m is repre-
sented by 5% or less of the total PP-population (Figs. 4 and 5).
Since these results reveal for the first time a non-gaussian
distribution of PP alterations in proteinuric states, a comparison
between values of mean PP-width—though used by us to
evaluate data available in the literature—seems no longer
appropriate to prove the existence of a correlation between the
extent of PP-alteration and the amount of proteinuria. For this
reason, and furthermore, to visualize the importance of PP-
alteration in proteinuric conditions, we choose bar area dia-
grams to represent the percentage capillary loop covered by PP
of four width classes (Figs. 4 and 5). In general, as shown in
Figure 5, 40 to 60% of the peripheral capillary loops are still
covered by PP of normal width in proteinuric conditions, while
the remaining area is covered by abnormally widened pro-
cesses. The area covered by such abnormal PP represents
between 40 and 60%. If we compare these results in terms of the
different disease entities, it is clear from Figure 5 that in
nephrotic states the area covered by PP of more than 7.0 p.m is
on average higher than in conditions with milder proteinuric
changes.
Although in all groups we observe a certain amount of
variation of the percentage of capillary loops covered by
flattened PP even at the same level of proteinuria, this is
especially prominent in MCD—cases (in Fig. 4 for example,
compare in children cases 2 and 3, in adults cases 6 and 7).
Thus, as in the other types of glomerular disorders, we find no
correlation between the extent of PP-width and the amount of
proteinuria in MCD in children or in adults.
In conclusion, flattening and retraction of PP is a common,
non-specific finding in proteinuric states caused by different
immunological mechanisms and is, as such, an epiphenomenon
which only indicates an altered permselectivity of the GCW,
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but is not correlated to the degree of proteinuria. The functional
expression of this damage at the glomerular filter seems to be
determined by interrelating factors: the immunologically—medi-
ated glomerular damage may lead to a loss of electrophysical
properties of the GCW and may, at the same time, cause
additional hemodynamic adaptations that vary from one patient
to another, possibly induced by action of vasoactive hormones
[26]. Altogether these interactions may contribute to the dif-
ferent functional expression of the same disease with variable
degrees of proteinutia, while at the same time the demonstrable
morphologic damage appears to be of similar intensity.
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